Oncology

Four takeaways from ASCO24

Last weekend, I travelled to Chicago for the annual conference of the American Society of Clinical Oncologists— the annual event where major breakthroughs in cancer care are announced.

Oncology

Building resilience in cancer trials

Clinical trials are a cornerstone of oncology research, vital for turning scientific breakthroughs into effective cancer treatments.

R&D

ASCO 2024 - Suzanne Trudel

Sometimes getting a new drug to market is a relatively straight line, but sometimes it’s a winding road.

News

Geron finally brings a drug to market as FDA clears Rytelo

More than 30 years after it was first founded, Geron has claimed FDA approval for its first product – myelodysplastic syndromes (MDS) treatment Rytelo.

News

ASCO: Moderna may file melanoma vaccine on phase 2b data

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme

News

ASCO: DREAMM-8 data puts GSK’s Blenrep back on track

GSK is increasingly confident that its anti-BCMA drug Blenrep could be returned to the US market, after revealing data from the DREAMM-8 trial of the drug in multiple myel

Four takeaways from ASCO24

Building resilience in cancer trials

ASCO 2024 - Suzanne Trudel

Geron finally brings a drug to market as FDA clears Rytelo

ASCO: Moderna may file melanoma vaccine on phase 2b data

ASCO: DREAMM-8 data puts GSK’s Blenrep back on track

Which biotechs have raised new VC financing this week?

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks